September 1st, 2010 by Davis Liu, M.D. in Better Health Network, Health Policy, Opinion
No Comments »
Everyone understands the need for a robust primary care workforce in making healthcare more affordable and accessible while keeping those in our care healthy. With the aging of America and healthcare reform, even more Americans will need primary care doctors at precisely the same time doctors are leaving the specialty in droves and medical students shun the career choice.
As a practicing primary care doctor, I’ve watched with great interest the solutions for the primary care crisis. And I’ve been utterly disappointed.
Patients so far don’t like the patient-centered medical home (PCMH) as noted in Dr. Pauline Chen’s New York Times column. The changes recommended won’t inspire the next generation of doctors to become internists and family doctors. Read more »
*This blog post was originally published at Saving Money and Surviving the Healthcare Crisis*
September 1st, 2010 by SteveSimmonsMD in Better Health Network, Health Policy, Opinion, Primary Care Wednesdays, True Stories
1 Comment »
As a primary care physician, I am becoming painfully aware of how hard it is to be good –- I mean really good — at what we do today. I would prefer to believe that it has always been so, yet I do not believe that our predecessors in the medical profession found it nearly as difficult to excel in their time as we do now.
With all of the technological and medical advances, you might ask how I could believe this to be true. Too, you might consider it pessimistic or even crazy to suggest that physicians 20, 30, or 100 years ago found it easier to practice medicine well in their time.
You could counter with numerous or obvious examples such as antibiotics, pharmaceuticals, robotic surgical procedures, or even our wondrous ability to peer inside the human body without cutting it open. You also would be correct to point out that the technological advancements of the 20th century opened the way for the medical profession to become a real science thus giving me and my colleagues the chance and knowledge to make a real difference in our patients’ lives today. Read more »
August 25th, 2010 by Toni Brayer, M.D. in Better Health Network, Health Policy, News, Opinion, Research
No Comments »
The top moneymakers for the U.S. pharmaceutical industry might surprise you. These aren’t necessarily the most prescribed medications (although some of them are), but they’re the top products in terms of sales in 2009. The revenues were in billions:
1. Lipitor – used for high cholesterol: $7.5 billion
2. Nexium – a proton pump inhibitor for GERD: $6.3 billion
3. Plavix – a blood thinner: $5.6 billion
4. Advair Diskus – used for asthma and COPD: $4.7 billion Read more »
*This blog post was originally published at EverythingHealth*
August 23rd, 2010 by DrRich in Better Health Network, Health Policy, News, Opinion, Research
2 Comments »
DrRich has pointed out several times that it is very important to our new healthcare system, as a matter of principle, to be able to discriminate against the obese.
The obese are being carefully groomed as a prototype, as a group whose characteristics (ostensibly, their lack of self-discipline, or their sloth, or their selfishness, or whatever other characteristics we can attribute to them to explain how their unsightly enormity differentiates them from us), will justify “special treatment” in order to serve the overriding good of the whole.
The obese are a useful target for two reasons. First, their sins against humanity are painfully obvious just by looking at them, so it is impossible for them to escape public scorn by blending in to the population, unlike some less obvious sinners such as (say) closet smokers, or pedophiles. And second, since true morbid obesity almost always has a strong genetic component, successfully demonizing the obese eventually will open the door to the demonization of individuals with any one of a host of other genetically mediated medical conditions. Read more »
*This blog post was originally published at The Covert Rationing Blog*
August 19th, 2010 by Debra Gordon in Better Health Network, Health Policy, News, Opinion, Research
No Comments »
Time to get back up on my soap box.
Next month the FDA is supposed to consider taking the unique, first-time-ever step of revoking a drug’s indication not because it’s dangerous, but because it doesn’t work well enough to offset its risks. Never mind that it costs about $8,000 a month.
The drug is Avastin (bevacizumab), a targeted monoclonal antibody that prevents tumors from creating and maintaining their own blood supply, a process called angiogenesis. Without oxygen and nutrients from blood, tumors can’t keep growing.
Avastin is the world’s best-selling cancer drug, approved for use with chemotherapy to treat lung cancer and metastatic colorectal and breast cancer. It is also being investigated (and, likely, being prescribed off label) for numerous other cancers. The problem comes with breast cancer. Read more »
*This blog post was originally published at A Medical Writer's Musings on Medicine, Health Care, and the Writing Life*
